The global Oral Peptide Therapeutics market was valued at million in 2024 and is projected to reach US$ million by 2032, at a CAGR of %during the forecast period.
The U.S. market is estimated at $ million in 2024, while China is to reach $ million.
Innovative Type segment will reach $ million by 2032, with a % CAGR in next six years.
The global key players of Oral Peptide Therapeutics include Sanofi, Teva, Novo Nordisk, Takeda, Eli Lilly, AstraZeneca, Novartis, AbbVie, Ipsen, Ferring, etc. In 2024, the global top five players had a share approximately % in terms of revenue.
We have surveyed the Oral Peptide Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Oral Peptide Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Peptide Therapeutics. This report contains market size and forecasts of Oral Peptide Therapeutics in global, including the following market information:
Global Oral Peptide Therapeutics market revenue, 2020-2025, 2026-2032, ($ millions)
Global top five Oral Peptide Therapeutics companies in 2024 (%)
Total Market by Segment:
Global Oral Peptide Therapeutics market, by Type, 2020-2025, 2026-2032 ($ millions)
Global Oral Peptide Therapeutics market segment percentages, by Type, 2024 (%)
Innovative Type
Generic Type
Global Oral Peptide Therapeutics market, by Application, 2020-2025, 2026-2032 ($ millions)
Global Oral Peptide Therapeutics market segment percentages, by Application, 2024 (%)
Cancer
Metabolic Disorders
Central Nervous System
Other
Global Oral Peptide Therapeutics market, by region and country, 2020-2025, 2026-2032 ($ millions)
Global Oral Peptide Therapeutics market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Oral Peptide Therapeutics revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Oral Peptide Therapeutics revenues share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
Teva
Novo Nordisk
Takeda
Eli Lilly
AstraZeneca
Novartis
AbbVie
Ipsen
Ferring
Merck
The Medicines
J & J
Outline of Major Chapters:
Chapter 1: Introduces the definition of Oral Peptide Therapeutics, market overview.
Chapter 2: Global Oral Peptide Therapeutics market size in revenue.
Chapter 3: Detailed analysis of Oral Peptide Therapeutics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Oral Peptide Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Oral Peptide Therapeutics Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Oral Peptide Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Oral Peptide Therapeutics Overall Market Size
2.1 Global Oral Peptide Therapeutics Market Size: 2024 VS 2032
2.2 Global Oral Peptide Therapeutics Market Size, Prospects & Forecasts: 2020-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Oral Peptide Therapeutics Players in Global Market
3.2 Top Global Oral Peptide Therapeutics Companies Ranked by Revenue
3.3 Global Oral Peptide Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Oral Peptide Therapeutics Companies in Global Market, by Revenue in 2024
3.5 Global Companies Oral Peptide Therapeutics Product Type
3.6 Tier 1, Tier 2, and Tier 3 Oral Peptide Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Oral Peptide Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Oral Peptide Therapeutics Companies
4 Sights by Product
4.1 Overview
4.1.1 Segmentation by Type - Global Oral Peptide Therapeutics Market Size Markets, 2024 & 2032
4.1.2 Innovative Type
4.1.3 Generic Type
4.2 Segmentation by Type - Global Oral Peptide Therapeutics Revenue & Forecasts
4.2.1 Segmentation by Type - Global Oral Peptide Therapeutics Revenue, 2020-2025
4.2.2 Segmentation by Type - Global Oral Peptide Therapeutics Revenue, 2026-2032
4.2.3 Segmentation by Type - Global Oral Peptide Therapeutics Revenue Market Share, 2020-2032
5 Sights by Application
5.1 Overview
5.1.1 Segmentation by Application - Global Oral Peptide Therapeutics Market Size, 2024 & 2032
5.1.2 Cancer
5.1.3 Metabolic Disorders
5.1.4 Central Nervous System
5.1.5 Other
5.2 Segmentation by Application - Global Oral Peptide Therapeutics Revenue & Forecasts
5.2.1 Segmentation by Application - Global Oral Peptide Therapeutics Revenue, 2020-2025
5.2.2 Segmentation by Application - Global Oral Peptide Therapeutics Revenue, 2026-2032
5.2.3 Segmentation by Application - Global Oral Peptide Therapeutics Revenue Market Share, 2020-2032
6 Sights by Region
6.1 By Region - Global Oral Peptide Therapeutics Market Size, 2024 & 2032
6.2 By Region - Global Oral Peptide Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Oral Peptide Therapeutics Revenue, 2020-2025
6.2.2 By Region - Global Oral Peptide Therapeutics Revenue, 2026-2032
6.2.3 By Region - Global Oral Peptide Therapeutics Revenue Market Share, 2020-2032
6.3 North America
6.3.1 By Country - North America Oral Peptide Therapeutics Revenue, 2020-2032
6.3.2 United States Oral Peptide Therapeutics Market Size, 2020-2032
6.3.3 Canada Oral Peptide Therapeutics Market Size, 2020-2032
6.3.4 Mexico Oral Peptide Therapeutics Market Size, 2020-2032
6.4 Europe
6.4.1 By Country - Europe Oral Peptide Therapeutics Revenue, 2020-2032
6.4.2 Germany Oral Peptide Therapeutics Market Size, 2020-2032
6.4.3 France Oral Peptide Therapeutics Market Size, 2020-2032
6.4.4 U.K. Oral Peptide Therapeutics Market Size, 2020-2032
6.4.5 Italy Oral Peptide Therapeutics Market Size, 2020-2032
6.4.6 Russia Oral Peptide Therapeutics Market Size, 2020-2032
6.4.7 Nordic Countries Oral Peptide Therapeutics Market Size, 2020-2032
6.4.8 Benelux Oral Peptide Therapeutics Market Size, 2020-2032
6.5 Asia
6.5.1 By Region - Asia Oral Peptide Therapeutics Revenue, 2020-2032
6.5.2 China Oral Peptide Therapeutics Market Size, 2020-2032
6.5.3 Japan Oral Peptide Therapeutics Market Size, 2020-2032
6.5.4 South Korea Oral Peptide Therapeutics Market Size, 2020-2032
6.5.5 Southeast Asia Oral Peptide Therapeutics Market Size, 2020-2032
6.5.6 India Oral Peptide Therapeutics Market Size, 2020-2032
6.6 South America
6.6.1 By Country - South America Oral Peptide Therapeutics Revenue, 2020-2032
6.6.2 Brazil Oral Peptide Therapeutics Market Size, 2020-2032
6.6.3 Argentina Oral Peptide Therapeutics Market Size, 2020-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Oral Peptide Therapeutics Revenue, 2020-2032
6.7.2 Turkey Oral Peptide Therapeutics Market Size, 2020-2032
6.7.3 Israel Oral Peptide Therapeutics Market Size, 2020-2032
6.7.4 Saudi Arabia Oral Peptide Therapeutics Market Size, 2020-2032
6.7.5 UAE Oral Peptide Therapeutics Market Size, 2020-2032
7 Companies Profiles
7.1 Sanofi
7.1.1 Sanofi Corporate Summary
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Oral Peptide Therapeutics Major Product Offerings
7.1.4 Sanofi Oral Peptide Therapeutics Revenue in Global Market (2020-2025)
7.1.5 Sanofi Key News & Latest Developments
7.2 Teva
7.2.1 Teva Corporate Summary
7.2.2 Teva Business Overview
7.2.3 Teva Oral Peptide Therapeutics Major Product Offerings
7.2.4 Teva Oral Peptide Therapeutics Revenue in Global Market (2020-2025)
7.2.5 Teva Key News & Latest Developments
7.3 Novo Nordisk
7.3.1 Novo Nordisk Corporate Summary
7.3.2 Novo Nordisk Business Overview
7.3.3 Novo Nordisk Oral Peptide Therapeutics Major Product Offerings
7.3.4 Novo Nordisk Oral Peptide Therapeutics Revenue in Global Market (2020-2025)
7.3.5 Novo Nordisk Key News & Latest Developments
7.4 Takeda
7.4.1 Takeda Corporate Summary
7.4.2 Takeda Business Overview
7.4.3 Takeda Oral Peptide Therapeutics Major Product Offerings
7.4.4 Takeda Oral Peptide Therapeutics Revenue in Global Market (2020-2025)
7.4.5 Takeda Key News & Latest Developments
7.5 Eli Lilly
7.5.1 Eli Lilly Corporate Summary
7.5.2 Eli Lilly Business Overview
7.5.3 Eli Lilly Oral Peptide Therapeutics Major Product Offerings
7.5.4 Eli Lilly Oral Peptide Therapeutics Revenue in Global Market (2020-2025)
7.5.5 Eli Lilly Key News & Latest Developments
7.6 AstraZeneca
7.6.1 AstraZeneca Corporate Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Oral Peptide Therapeutics Major Product Offerings
7.6.4 AstraZeneca Oral Peptide Therapeutics Revenue in Global Market (2020-2025)
7.6.5 AstraZeneca Key News & Latest Developments
7.7 Novartis
7.7.1 Novartis Corporate Summary
7.7.2 Novartis Business Overview
7.7.3 Novartis Oral Peptide Therapeutics Major Product Offerings
7.7.4 Novartis Oral Peptide Therapeutics Revenue in Global Market (2020-2025)
7.7.5 Novartis Key News & Latest Developments
7.8 AbbVie
7.8.1 AbbVie Corporate Summary
7.8.2 AbbVie Business Overview
7.8.3 AbbVie Oral Peptide Therapeutics Major Product Offerings
7.8.4 AbbVie Oral Peptide Therapeutics Revenue in Global Market (2020-2025)
7.8.5 AbbVie Key News & Latest Developments
7.9 Ipsen
7.9.1 Ipsen Corporate Summary
7.9.2 Ipsen Business Overview
7.9.3 Ipsen Oral Peptide Therapeutics Major Product Offerings
7.9.4 Ipsen Oral Peptide Therapeutics Revenue in Global Market (2020-2025)
7.9.5 Ipsen Key News & Latest Developments
7.10 Ferring
7.10.1 Ferring Corporate Summary
7.10.2 Ferring Business Overview
7.10.3 Ferring Oral Peptide Therapeutics Major Product Offerings
7.10.4 Ferring Oral Peptide Therapeutics Revenue in Global Market (2020-2025)
7.10.5 Ferring Key News & Latest Developments
7.11 Merck
7.11.1 Merck Corporate Summary
7.11.2 Merck Business Overview
7.11.3 Merck Oral Peptide Therapeutics Major Product Offerings
7.11.4 Merck Oral Peptide Therapeutics Revenue in Global Market (2020-2025)
7.11.5 Merck Key News & Latest Developments
7.12 The Medicines
7.12.1 The Medicines Corporate Summary
7.12.2 The Medicines Business Overview
7.12.3 The Medicines Oral Peptide Therapeutics Major Product Offerings
7.12.4 The Medicines Oral Peptide Therapeutics Revenue in Global Market (2020-2025)
7.12.5 The Medicines Key News & Latest Developments
7.13 J & J
7.13.1 J & J Corporate Summary
7.13.2 J & J Business Overview
7.13.3 J & J Oral Peptide Therapeutics Major Product Offerings
7.13.4 J & J Oral Peptide Therapeutics Revenue in Global Market (2020-2025)
7.13.5 J & J Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Oral Peptide Therapeutics Market Opportunities & Trends in Global Market
Table 2. Oral Peptide Therapeutics Market Drivers in Global Market
Table 3. Oral Peptide Therapeutics Market Restraints in Global Market
Table 4. Key Players of Oral Peptide Therapeutics in Global Market
Table 5. Top Oral Peptide Therapeutics Players in Global Market, Ranking by Revenue (2024)
Table 6. Global Oral Peptide Therapeutics Revenue by Companies, (US$, Mn), 2020-2025
Table 7. Global Oral Peptide Therapeutics Revenue Share by Companies, 2020-2025
Table 8. Global Companies Oral Peptide Therapeutics Product Type
Table 9. List of Global Tier 1 Oral Peptide Therapeutics Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Oral Peptide Therapeutics Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segmentation by Type � Global Oral Peptide Therapeutics Revenue, (US$, Mn), 2024 & 2032
Table 12. Segmentation by Type - Global Oral Peptide Therapeutics Revenue (US$, Mn), 2020-2025
Table 13. Segmentation by Type - Global Oral Peptide Therapeutics Revenue (US$, Mn), 2026-2032
Table 14. Segmentation by Application� Global Oral Peptide Therapeutics Revenue, (US$, Mn), 2024 & 2032
Table 15. Segmentation by Application - Global Oral Peptide Therapeutics Revenue, (US$, Mn), 2020-2025
Table 16. Segmentation by Application - Global Oral Peptide Therapeutics Revenue, (US$, Mn), 2026-2032
Table 17. By Region� Global Oral Peptide Therapeutics Revenue, (US$, Mn), 2024 & 2032
Table 18. By Region - Global Oral Peptide Therapeutics Revenue, (US$, Mn), 2020-2025
Table 19. By Region - Global Oral Peptide Therapeutics Revenue, (US$, Mn), 2026-2032
Table 20. By Country - North America Oral Peptide Therapeutics Revenue, (US$, Mn), 2020-2025
Table 21. By Country - North America Oral Peptide Therapeutics Revenue, (US$, Mn), 2026-2032
Table 22. By Country - Europe Oral Peptide Therapeutics Revenue, (US$, Mn), 2020-2025
Table 23. By Country - Europe Oral Peptide Therapeutics Revenue, (US$, Mn), 2026-2032
Table 24. By Region - Asia Oral Peptide Therapeutics Revenue, (US$, Mn), 2020-2025
Table 25. By Region - Asia Oral Peptide Therapeutics Revenue, (US$, Mn), 2026-2032
Table 26. By Country - South America Oral Peptide Therapeutics Revenue, (US$, Mn), 2020-2025
Table 27. By Country - South America Oral Peptide Therapeutics Revenue, (US$, Mn), 2026-2032
Table 28. By Country - Middle East & Africa Oral Peptide Therapeutics Revenue, (US$, Mn), 2020-2025
Table 29. By Country - Middle East & Africa Oral Peptide Therapeutics Revenue, (US$, Mn), 2026-2032
Table 30. Sanofi Corporate Summary
Table 31. Sanofi Oral Peptide Therapeutics Product Offerings
Table 32. Sanofi Oral Peptide Therapeutics Revenue (US$, Mn) & (2020-2025)
Table 33. Sanofi Key News & Latest Developments
Table 34. Teva Corporate Summary
Table 35. Teva Oral Peptide Therapeutics Product Offerings
Table 36. Teva Oral Peptide Therapeutics Revenue (US$, Mn) & (2020-2025)
Table 37. Teva Key News & Latest Developments
Table 38. Novo Nordisk Corporate Summary
Table 39. Novo Nordisk Oral Peptide Therapeutics Product Offerings
Table 40. Novo Nordisk Oral Peptide Therapeutics Revenue (US$, Mn) & (2020-2025)
Table 41. Novo Nordisk Key News & Latest Developments
Table 42. Takeda Corporate Summary
Table 43. Takeda Oral Peptide Therapeutics Product Offerings
Table 44. Takeda Oral Peptide Therapeutics Revenue (US$, Mn) & (2020-2025)
Table 45. Takeda Key News & Latest Developments
Table 46. Eli Lilly Corporate Summary
Table 47. Eli Lilly Oral Peptide Therapeutics Product Offerings
Table 48. Eli Lilly Oral Peptide Therapeutics Revenue (US$, Mn) & (2020-2025)
Table 49. Eli Lilly Key News & Latest Developments
Table 50. AstraZeneca Corporate Summary
Table 51. AstraZeneca Oral Peptide Therapeutics Product Offerings
Table 52. AstraZeneca Oral Peptide Therapeutics Revenue (US$, Mn) & (2020-2025)
Table 53. AstraZeneca Key News & Latest Developments
Table 54. Novartis Corporate Summary
Table 55. Novartis Oral Peptide Therapeutics Product Offerings
Table 56. Novartis Oral Peptide Therapeutics Revenue (US$, Mn) & (2020-2025)
Table 57. Novartis Key News & Latest Developments
Table 58. AbbVie Corporate Summary
Table 59. AbbVie Oral Peptide Therapeutics Product Offerings
Table 60. AbbVie Oral Peptide Therapeutics Revenue (US$, Mn) & (2020-2025)
Table 61. AbbVie Key News & Latest Developments
Table 62. Ipsen Corporate Summary
Table 63. Ipsen Oral Peptide Therapeutics Product Offerings
Table 64. Ipsen Oral Peptide Therapeutics Revenue (US$, Mn) & (2020-2025)
Table 65. Ipsen Key News & Latest Developments
Table 66. Ferring Corporate Summary
Table 67. Ferring Oral Peptide Therapeutics Product Offerings
Table 68. Ferring Oral Peptide Therapeutics Revenue (US$, Mn) & (2020-2025)
Table 69. Ferring Key News & Latest Developments
Table 70. Merck Corporate Summary
Table 71. Merck Oral Peptide Therapeutics Product Offerings
Table 72. Merck Oral Peptide Therapeutics Revenue (US$, Mn) & (2020-2025)
Table 73. Merck Key News & Latest Developments
Table 74. The Medicines Corporate Summary
Table 75. The Medicines Oral Peptide Therapeutics Product Offerings
Table 76. The Medicines Oral Peptide Therapeutics Revenue (US$, Mn) & (2020-2025)
Table 77. The Medicines Key News & Latest Developments
Table 78. J & J Corporate Summary
Table 79. J & J Oral Peptide Therapeutics Product Offerings
Table 80. J & J Oral Peptide Therapeutics Revenue (US$, Mn) & (2020-2025)
Table 81. J & J Key News & Latest Developments
List of Figures
Figure 1. Oral Peptide Therapeutics Product Picture
Figure 2. Oral Peptide Therapeutics Segment by Type in 2024
Figure 3. Oral Peptide Therapeutics Segment by Application in 2024
Figure 4. Global Oral Peptide Therapeutics Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Oral Peptide Therapeutics Market Size: 2024 VS 2032 (US$, Mn)
Figure 7. Global Oral Peptide Therapeutics Revenue: 2020-2032 (US$, Mn)
Figure 8. The Top 3 and 5 Players Market Share by Oral Peptide Therapeutics Revenue in 2024
Figure 9. Segmentation by Type � Global Oral Peptide Therapeutics Revenue, (US$, Mn), 2024 & 2032
Figure 10. Segmentation by Type - Global Oral Peptide Therapeutics Revenue Market Share, 2020-2032
Figure 11. Segmentation by Application � Global Oral Peptide Therapeutics Revenue, (US$, Mn), 2024 & 2032
Figure 12. Segmentation by Application - Global Oral Peptide Therapeutics Revenue Market Share, 2020-2032
Figure 13. By Region - Global Oral Peptide Therapeutics Revenue Market Share, 2020-2032
Figure 14. By Country - North America Oral Peptide Therapeutics Revenue Market Share, 2020-2032
Figure 15. United States Oral Peptide Therapeutics Revenue, (US$, Mn), 2020-2032
Figure 16. Canada Oral Peptide Therapeutics Revenue, (US$, Mn), 2020-2032
Figure 17. Mexico Oral Peptide Therapeutics Revenue, (US$, Mn), 2020-2032
Figure 18. By Country - Europe Oral Peptide Therapeutics Revenue Market Share, 2020-2032
Figure 19. Germany Oral Peptide Therapeutics Revenue, (US$, Mn), 2020-2032
Figure 20. France Oral Peptide Therapeutics Revenue, (US$, Mn), 2020-2032
Figure 21. U.K. Oral Peptide Therapeutics Revenue, (US$, Mn), 2020-2032
Figure 22. Italy Oral Peptide Therapeutics Revenue, (US$, Mn), 2020-2032
Figure 23. Russia Oral Peptide Therapeutics Revenue, (US$, Mn), 2020-2032
Figure 24. Nordic Countries Oral Peptide Therapeutics Revenue, (US$, Mn), 2020-2032
Figure 25. Benelux Oral Peptide Therapeutics Revenue, (US$, Mn), 2020-2032
Figure 26. By Region - Asia Oral Peptide Therapeutics Revenue Market Share, 2020-2032
Figure 27. China Oral Peptide Therapeutics Revenue, (US$, Mn), 2020-2032
Figure 28. Japan Oral Peptide Therapeutics Revenue, (US$, Mn), 2020-2032
Figure 29. South Korea Oral Peptide Therapeutics Revenue, (US$, Mn), 2020-2032
Figure 30. Southeast Asia Oral Peptide Therapeutics Revenue, (US$, Mn), 2020-2032
Figure 31. India Oral Peptide Therapeutics Revenue, (US$, Mn), 2020-2032
Figure 32. By Country - South America Oral Peptide Therapeutics Revenue Market Share, 2020-2032
Figure 33. Brazil Oral Peptide Therapeutics Revenue, (US$, Mn), 2020-2032
Figure 34. Argentina Oral Peptide Therapeutics Revenue, (US$, Mn), 2020-2032
Figure 35. By Country - Middle East & Africa Oral Peptide Therapeutics Revenue Market Share, 2020-2032
Figure 36. Turkey Oral Peptide Therapeutics Revenue, (US$, Mn), 2020-2032
Figure 37. Israel Oral Peptide Therapeutics Revenue, (US$, Mn), 2020-2032
Figure 38. Saudi Arabia Oral Peptide Therapeutics Revenue, (US$, Mn), 2020-2032
Figure 39. UAE Oral Peptide Therapeutics Revenue, (US$, Mn), 2020-2032
Figure 40. Sanofi Oral Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 41. Teva Oral Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 42. Novo Nordisk Oral Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 43. Takeda Oral Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 44. Eli Lilly Oral Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 45. AstraZeneca Oral Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 46. Novartis Oral Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 47. AbbVie Oral Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 48. Ipsen Oral Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 49. Ferring Oral Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 50. Merck Oral Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 51. The Medicines Oral Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 52. J & J Oral Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
